MTNB — Matinas BioPharma Holdings, Inc.
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 1582554 ·
Last close
$0.73
Market Cap
$4.66M
52W High
$0.79
52W Low
$0.48
ADV30
258,954
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -1,936,000 | -1,921,000 | 5,874,000 | 2,398,000 | 2,852,000 |
| Dec 2025 | 0 | — | -1,600,000 | -1,912,000 | 7,208,000 | 3,999,000 | 2,378,000 |
| Sep 2025 | 0 | — | -1,577,000 | -1,532,000 | 9,695,000 | 5,435,000 | 3,235,000 |
| Jun 2025 | 0 | — | -1,837,000 | -5,245,000 | 11,424,000 | 6,525,000 | 3,749,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-7,011,000
Investing CF
$335,000
Financing CF
$3,391,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.61
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-210,787,000
Inventory
—
Receivables
—
ST Investments
$0
EBIT TTM
$-6,960,000
Pretax Income TTM
$-10,345,000
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -6,960,000 | -10,345,000 | 7,208,000 | 2,378,000 | — | -7,011,000 |
| Dec 2024 | 0 | -20,162,000 | -24,251,000 | 12,641,000 | 5,051,000 | — | -15,885,000 |
| Dec 2023 | 1,096,000 | -23,766,000 | -22,942,000 | 25,104,000 | 5,858,000 | — | -15,278,000 |
| Dec 2022 | 3,188,000 | -24,590,000 | -20,997,000 | 44,819,000 | 8,182,000 | — | -19,156,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-3.00
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PMHS | Polomar Health Services, Inc. | $4.56M | $0.15 | — |
| ADIL | ADIAL PHARMACEUTICALS, INC. | $4.80M | $2.24 | — |
| GELS | Gelteq Ltd | $4.52M | $0.42 | — |
| ENSC | Ensysce Biosciences, Inc. | $4.52M | $0.31 | — |
| CTTH | CTT PHARMACEUTICAL HOLDINGS, INC. | $4.85M | $0.08 | — |
News headlines (Yahoo Finance, 1h cache)
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
2026-04-03 21:00 · Yahoo
Matinas BioPharma Holdings, Inc. (MTNB) Restructures Amid Challenges, Focuses on Oral Antifungal MAT2203
2025-09-23 23:22 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.